Vivosim Lab Inc VIVS

$0.15 -0.01 (-5.90%)

Valuation

Market cap
2,644,000
Revenue TTM
$130,000
Net income TTM
$-13,840,000
PE ratio
0.00
Forward PE
—
Profit margin
-10,646.15%
Debt to equity
0.00

Trading

Volume
745,600
Avg volume
948,054
Day's range
$0.14 – $0.16
Shares out
16,586,000
Stochastic %K
9%
Beta
1.49
Analysts
Strong Buy
Price target
$64.83

Price

Company profile

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting...

Show more

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and build functional 3D human tissues through its proprietary technologies that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Industry
Biotechnology
Sector
Healthcare
Phone
858 224 1000
Website
https://vivosim.ai
Address
11555 Sorrento Valley Road, Suite 100, San Diego, United States

Latest news

Stocktwits

RetiredOldGeezer Oct 23, 5:52 PM
$VIVS If each executive skipped their Happy Meal, Fancy Coffee, and their massage - they could double the number of shares the Sales guy has and maybe he could sell some clients - a test cost less than the car he probably drives. But no selling 15 cent stock and diluting shareholders is so easy.
0 replies
RetiredOldGeezer Oct 23, 1:44 PM
$VIVS They must all be busy networking and looking for next 2 year gig - Uber is always looking for drivers.
0 replies
NewsAndFilings Oct 23, 1:05 AM
Watch Now: $VIVS, $IGC, $XXII and $SHFS Low Price Listed Stocks in Focus https://thestreetreports.com/watch-now-vivs-igc-xxii-and-shfs-low-price-listed-stocks-in-focus/
0 replies
NewsAndFilings Oct 23, 12:26 AM
Yesterdays Recap: $PRSO Demonstrates 60 GHz Wireless Connectivity for Humanoid Robots $VIVS Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker Profiling $GMG Provides G(R)CELLS to Potential Customers for Early Performance Testing
0 replies
JSP_Dilution_Player Oct 22, 7:58 PM
$VIVS let's go up.
0 replies
JSP_Dilution_Player Oct 22, 7:08 PM
$VIVS will give it a day or two to see how it does. 12% drop on no reason
0 replies
JSP_Dilution_Player Oct 22, 5:40 PM
$VIVS algo is sleeping at the moment
0 replies
JSP_Dilution_Player Oct 22, 5:01 PM
$VIVS added starter to see if this gets going back up. looks like they do have cash.
0 replies